French physicians group says that all patients exhibiting fever should be given Corona test. Upon diagnosis and after normal precautions, all patients should be prescribed combination of hydroxychloroquine and Azithromycin

.
Added: Mylan’s hydroxychloroquine sulfate tablets are already approved by the U.S. Food and Drug Administration (FDA) for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.

..............................

French physicians group in accord with their Hippocratic Oath, affirm that all patients exhibiting fever should be given Corona test; upon diagnosis, patients should immediately be given the combination of hydroxychloroquine and Azithromycin: 

3/22/20, “COVID-19 CORONAVIRUS OUTBREAK,” Mediterranee Infection, Marseille. Translation from French by computer 

“In the current context of the spread of the Covid-19 coronavirus epidemic on French territory and worldwide. In accordance with the Hippocratic Oath that we have taken, we obey our duty as a doctor. We provide our patients with the best care for the diagnosis and treatment of a disease. We respect the rules of the art and the most recently acquired data from medical science. 

We decided:  

· For all febrile patients who come to consult us, to practice the tests for the diagnosis of infection with Covid 19;

· For all infected patients, many of whom are not very symptomatic and have pulmonary lesions on CT, we propose at the earliest stage of the disease, as soon as the diagnosis is made: – treatment with the hydroxychloroquine combination (200 mg x 3 per day for 10 days) + Azithromycin (500 mg on the 1st day then 250 mg per day for 5 more days), as part of the precautions for use of this combination (with in particular an electrocardiogram on D0 and D2), and outside of marketing authorization. In cases of severe pneumonia, a broad-spectrum antibiotic is also used. 

We think that it is not moral that this association is not systematically included in the therapeutic trials concerning the treatment of Covid-19 infection in France. 

Pr Philippe Brouqui, Pr Jean-Christophe Lagier, Pr Matthieu Million, Pr Philippe Parola, Pr Didier Raoult, Dr Marie Hocquart”
..

---

“Funded by the Investments for the Future Program, the Institut Hospitalo Universitaire Méditerranée Infection is a research, care, training and development center specializing in the fight against infectious diseases. It is chaired by Professor Didier Raoult, the most cited microbiologist in Europe. 

The founding members of the IHU Méditerranée Infection are: Aix-Marseille University, the Assistance Publique Hôpitaux de Marseille, the Research Institute for Development, the Army Health Service, the Mérieux Foundation, the French Blood Establishment and the National Institute of Health and Medical Research. 

The IHU Méditerranée Infection was built thanks to financial support from the Investments for the Future Program piloted by the General Secretariat for Investment, the European Regional Development Fund (ERDF), the National Research Agency, the Provence Alpes Côte d’Azur region, the Bouches du Rhône Department, the Aix-Marseille Provence Metropolis and the City of Marseille.”



.........
images from presse@mediterranee-infection.com